Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?

Thure Filskov Overvad; Flemming Skjøth; Ida Ehlers Albertsen; Torben Bjerregaard Larsen; Mette Søgaard; Professor Gregory Lip

doi:10.1016/j.amjmed.2020.05.042

Related publications

Article2020

SHOULD WE REINTRODUCE PREVIOUS VENOUS THROMBOEMBOLISM INTO DECISION-MAKING FOR ANTICOAGULATION IN ATRIAL FIBRILLATION? A NATIONWIDE COHORT STUDY

Thure Filskov Overvad, Flemming Skjøth, Ida Ehlers Albertsen, Torben Bjerregaard Larsen, Mette Søgaard, Professor Gregory Lip

Article2023

Venous Thromboembolism in Patients With Atrial Fibrillation

Daniele Pastori, Gianluca Gazzaniga, Alessio Farcomeni, Tommaso Bucci, Danilo Menichelli, Giovanni Franchino, Arianna Pani, Francesco Violi, Pasquale Pignatelli, Laurent Fauchier, Professor Gregory Lip

Article2019

Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study

Maria Cristina Vedovati, Gianpaolo Reboldi, Giancarlo Agnelli, Paolo Verdecchia

Article2013

Decision making for oral anticoagulants in atrial fibrillation: The ATA-AF study

Gualberto Gussoni, Giuseppe Di Pasquale, Giorgio Vescovo, Michele Massimo Gulizia, Giovanni Mathieu, Marino Scherillo, Domenico Panuccio, Donata Lucci, Carlo Nozzoli, Gianna Fabbri, Fabrizio Colombo, Letizia Riva, Concetta Baldo, Aldo Maggioni, Antonino Mazzone

Article2016

Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis

Raphaël Philippart, Anne Brunet-Bernard, Nicolas Clémenty, Thierry Bourguignon, Alain Mirza, Denis Angoulvant, Dominique Babuty, Professor Gregory Lip, Laurent Fauchier